| Company
| InsiderPie Expert Score
| P/E ratio
| Gross margin
| EBIT margin
| ROA
| Net income per employee
|
| Scope Fluidics S.A.
|
50
/ 100
| 6.9
| -1,599.3%
| -4,886.7%
| 39.0%
| €200.26K
|
| Intelligent Bio Solutions Inc.
|
50
/ 100
| -0.041
| 40.8%
| -348.7%
| -128.1%
| -€181.36K
|
| Stella Diagnostics Inc.
|
50
/ 100
| -3.2
| -62.2%
| -656.6%
| -417.6%
| -€638.01K
|
| Vimian Group AB (publ)
|
50
/ 100
| 8.2
| 68.7%
| 13.0%
| 2.0%
| €18.90K
|
| FALCO HOLDINGS Co., Ltd.
|
50
/ 100
| 12
| 31.2%
| 5.5%
| 5.4%
| €9.77K
|
| AroCell AB (publ)
|
50
/ 100
| -3
| 20.6%
| -75.1%
| -36.0%
| -€183.57K
|
| Wellfully Limited
|
50
/ 100
| -0.74
| 36.7%
| -138.7%
| -57.1%
| €0.00
|
| Genetic Technologies Limited
|
50
/ 100
| -0.24
| -11.2%
| -106.7%
| -384.2%
| -€246.25K
|
| Thyrocare Technologies Limited
|
50
/ 100
| 49
| 61.7%
| 29.1%
| 0.0%
| €5.99K
|
| Bioqual, Inc.
|
50
/ 100
| -38
| -3.9%
| -3.9%
| -1.8%
| -€3.23K
|
| Fulgent Genetics, Inc.
|
50
/ 100
| -15
| 41.2%
| -22.5%
| -3.5%
| -€28.09K
|
| Cryosite Limited
|
50
/ 100
| 11
| 58.2%
| 15.6%
| 17.9%
| €77.69K
|
| Fleury S.A.
|
50
/ 100
| 12
| 26.9%
| 15.0%
| 4.4%
| €3.46K
|
| Lumibird SA
|
50
/ 100
| 17
| 22.1%
| 9.1%
| 4.0%
| €16.78K
|
| NanoRepro AG
|
50
/ 100
| -3.1
| 40.3%
| -115.2%
| -17.2%
| -€305.96K
|
| PharmChem, Inc.
|
50
/ 100
| 15
| 63.7%
| 27.3%
| 50.5%
| €131.63K
|
| Exagen Inc.
|
50
/ 100
| -8.3
| 59.9%
| -19.6%
| -30.3%
| -€78.16K
|
| Guangzhou Kingmed Diagnostics Group Co., Ltd.
|
50
/ 100
| -25
| 32.5%
| -7.8%
| -5.7%
| -€6.48K
|
| Biodesix, Inc.
|
50
/ 100
| -1.2
| 57.8%
| -40.6%
| -44.6%
| -€124.26K
|
| PT Prodia Widyahusada Tbk
|
50
/ 100
| 12
| 56.0%
| 10.4%
| 8.7%
| €3.89K
|
| Verici Dx plc
|
50
/ 100
| -0.0038
| 99.9%
| -344.0%
| -195.0%
| -€659.67K
|
| PT Diagnos Laboratorium Utama Tbk
|
50
/ 100
| -78
| 41.4%
| -0.7%
| -0.8%
| -€1.36K
|
| Proteome Sciences plc
|
50
/ 100
| -0.012
| 99.9%
| 25.2%
| -88.8%
| -€235.38K
|
| NovelStem International Corp.
|
50
/ 100
| -0.82
| 100.0%
| -12,759.6%
| -11,174.7%
| €0.00
|
| Illumina, Inc.
|
62
/ 100
| 20
| 66.2%
| 18.3%
| 11.4%
| €67.24K
|
| Sapporo Clinical Laboratory Inc.
|
50
/ 100
| 7.8
| 30.5%
| 6.6%
| 2.8%
| €2.94K
|
| DarioHealth Corp.
|
50
/ 100
| -2.1
| 55.0%
| -158.5%
| -14.1%
| -€67.04K
|
| iMD Companies, Inc.
|
50
/ 100
| -1.8
| 19.3%
| -139.8%
| -121.0%
| €0.00
|
| Optigenex Inc.
|
50
/ 100
| -0.0000043
| -2.6%
| 178.3%
| -233.1%
| €0.00
|
| Beijing Strong Biotechnologies, Inc.
|
50
/ 100
| 19
| 80.1%
| 34.8%
| 8.2%
| €47.90K
|
| Genomic Vision SA
|
50
/ 100
| -0.044
| 67.2%
| -501.3%
| -396.1%
| -€475.00K
|
| IDEXX Laboratories, Inc.
|
73
/ 100
| 41
| 61.7%
| 31.3%
| 30.3%
| €80.14K
|
| Yourgene Health Plc
|
50
/ 100
| -0.014
| 61.1%
| -62.8%
| -23.1%
| -€51.23K
|
| Syneos Health, Inc.
|
50
/ 100
| 63
| 22.1%
| 5.4%
| 0.9%
| €2.12K
|
| Selvita S.A.
|
50
/ 100
| 1.1K
| 79.4%
| 2.6%
| 0.1%
| €113.43
|
| Burning Rock Biotech Limited
|
50
/ 100
| -1.1
| 72.1%
| -27.4%
| -17.0%
| -€25.26K
|
| Medicalsystem Biotechnology Co., Ltd.
|
50
/ 100
| 43
| 39.6%
| 4.4%
| 2.6%
| €5.43K
|
| Enzo Biochem, Inc.
|
50
/ 100
| -1.5
| 43.8%
| -39.0%
| -33.2%
| -€144.71K
|
| Microba Life Sciences Limited
|
50
/ 100
| -2.5
| 13.3%
| -123.8%
| -49.3%
| €0.00
|
| Myriad Genetics, Inc.
|
50
/ 100
| -1.2
| 70.4%
| -50.1%
| -58.3%
| -€125.59K
|
| Dirui Industrial Co.,Ltd.
|
50
/ 100
| -27
| 35.3%
| -34.9%
| -5.0%
| -€9.19K
|
| Shanghai Labway Clinical Laboratory Co., Ltd.
|
50
/ 100
| -29
| 21.9%
| -5.1%
| -5.2%
| -€11.63K
|
| Sotera Health Company
|
50
/ 100
| 63
| 56.0%
| 30.7%
| 1.7%
| €15.85K
|
| Exact Sciences Corporation
|
58
/ 100
| -11
| 67.4%
| -32.3%
| -16.7%
| -€122.68K
|
| Vijaya Diagnostic Centre Limited
|
50
/ 100
| 66
| 87.7%
| 39.7%
| 0.0%
| €6.97K
|
| Rhythm Biosciences Limited
|
50
/ 100
| -1.6
| 43.4%
| -185.1%
| -377.3%
| €0.00
|
| Aspira Women's Health Inc.
|
50
/ 100
| -0.31
| 63.9%
| -131.6%
| -191.6%
| -€122.90K
|
| Chemclin Diagnostics Co., Ltd.
|
50
/ 100
| 39
| 70.1%
| 20.7%
| 4.2%
| €12.42K
|
| Rennova Health, Inc.
|
50
/ 100
| -0.0056
| 59.5%
| 7.3%
| -38.2%
| -€69.08K
|
| Spectral Medical Inc.
|
50
/ 100
| -12
| 59.8%
| -461.5%
| -389.0%
| -€458.18K
|
| Healius Limited
|
50
/ 100
| -0.76
| 26.5%
| 8.5%
| -44.9%
| -€104.91K
|
| Lumos Diagnostics Holdings Limited
|
50
/ 100
| -1.2
| 61.8%
| -35.5%
| -39.7%
| €0.00
|
| OpGen, Inc.
|
50
/ 100
| 3.8
| 100.8%
| 41.2%
| 119.9%
| €114.03K
|
| Puriblood Medical Co., Ltd.
|
50
/ 100
| -20
| 31.5%
| -17.6%
| -21.0%
| -€33.26K
|
| Abingdon Health Plc
|
50
/ 100
| -0.028
| 48.5%
| -42.6%
| -49.1%
| -€48.79K
|
| Medpace Holdings, Inc.
|
57
/ 100
| 20
| 31.1%
| 21.5%
| 24.7%
| €62.97K
|
| Standard BioTools Inc.
|
50
/ 100
| -3.3
| 49.0%
| -79.9%
| -21.6%
| -€168.12K
|
| DIVA Laboratories, Ltd.
|
50
/ 100
| 26
| 31.0%
| 13.0%
| 6.3%
| €0.00
|
| Waters Corporation
|
71
/ 100
| 32
| 62.4%
| 26.5%
| 13.3%
| €73.25K
|
| Trinity Biotech plc
|
50
/ 100
| -0.35
| 32.1%
| -42.0%
| -37.4%
| -€84.16K
|
| Sera Prognostics, Inc.
|
50
/ 100
| -1.7
| -209.3%
| -34,125.0%
| -29.3%
| -€445.77K
|
| Devyser Diagnostics AB (publ)
|
50
/ 100
| -49
| 81.6%
| -16.2%
| -9.9%
| -€34.70K
|
| Meridian Bioscience, Inc.
|
50
/ 100
| -551
| 56.6%
| 2.1%
| -0.6%
| -€3.36K
|
| Epigenomics AG
|
50
/ 100
| -0.072
| 75.8%
| -1,263.3%
| -38.5%
| -€221.36K
|
| NeoGenomics, Inc.
|
50
/ 100
| -1.8
| 43.5%
| -17.0%
| -8.3%
| -€44.25K
|
| Interpace Biosciences, Inc.
|
50
/ 100
| 0.71
| 64.1%
| 14.0%
| 42.0%
| €40.03K
|
| Mettler-Toledo International Inc.
|
61
/ 100
| 30
| 59.7%
| 29.1%
| 23.7%
| €44.82K
|
| 23andMe Holding Co.
|
50
/ 100
| -0.057
| 53.3%
| -129.4%
| -163.0%
| -€360.53K
|
| Natera, Inc.
|
50
/ 100
| -90
| 62.9%
| -14.9%
| -14.4%
| -€49.11K
|
| Star Equity Holdings, Inc.
|
50
/ 100
| -1
| 23.8%
| -8.2%
| -6.4%
| -€28.89K
|
| Inotiv, Inc.
|
50
/ 100
| -1.1
| 20.6%
| -2.6%
| -10.4%
| -€34.27K
|
| WuXi AppTec Co., Ltd.
|
50
/ 100
| 14
| 43.8%
| 38.4%
| 16.4%
| €42.41K
|
| Joinn Laboratories(China)Co.,Ltd.
|
50
/ 100
| 49
| 26.0%
| 5.1%
| 3.2%
| €14.74K
|
| SenzaGen AB
|
50
/ 100
| -9.3
| 65.5%
| -32.4%
| -15.8%
| -€44.19K
|
| Precipio, Inc.
|
50
/ 100
| -13
| 47.5%
| -9.7%
| -5.9%
| -€19.92K
|
| PerkinElmer, Inc.
|
51
/ 100
| 46
| 59.1%
| 12.0%
| 2.0%
| €12.60K
|
| Predilife S.A.
|
50
/ 100
| -1.6
| -974.2%
| -1,221.2%
| -347.4%
| -€446.78K
|
| ANGLE plc
|
50
/ 100
| -1.1
| 62.3%
| -627.7%
| -87.3%
| -€120.28K
|
| Biocept, Inc.
|
50
/ 100
| -0.013
| 555.8%
| 1,088.2%
| -157.9%
| -€598.92K
|
| Quest Diagnostics Incorporated
|
50
/ 100
| 20
| 33.3%
| 14.0%
| 6.0%
| €15.10K
|
| Response Genetics, Inc
|
50
/ 100
| -0.00026
| 40.5%
| -79.3%
| -137.7%
| -€132.67K
|
| Ever Fortune.AI Co., Ltd.
|
50
/ 100
| 94
| 62.4%
| 10.5%
| 3.5%
| €0.00
|
| T2 Biosystems, Inc.
|
50
/ 100
| -0.093
| -77.7%
| -542.6%
| -237.6%
| -€326.15K
|
| BioPorto A/S
|
50
/ 100
| -7.6
| 62.3%
| -256.6%
| -95.8%
| -€235.34K
|
| Synlab AG
|
50
/ 100
| 27
| 49.8%
| 5.2%
| 1.9%
| €3.31K
|
| OPKO Health, Inc.
|
48
/ 100
| -7.6
| 38.6%
| -17.5%
| -7.1%
| -€40.31K
|
| Bionano Genomics, Inc.
|
50
/ 100
| -0.17
| 6.8%
| -262.9%
| -97.8%
| -€650.77K
|
| Imagion Biosystems Limited
|
50
/ 100
| -0.28
| 26.3%
| -307.5%
| -913.6%
| €0.00
|
| Sonic Healthcare Limited
|
50
/ 100
| 13
| 31.3%
| 25.2%
| 6.4%
| €13.90K
|
| Medivolve Inc.
|
50
/ 100
| -0.057
| 58.9%
| -228.5%
| -597.4%
| -€351.47K
|
| BGI Genomics Co., Ltd.
|
50
/ 100
| -23
| 39.9%
| -25.2%
| -7.3%
| -€30.01K
|
| Shin Nippon Biomedical Laboratories, Ltd.
|
50
/ 100
| 11
| 49.8%
| 7.2%
| 5.7%
| €19.17K
|
| Aclaris Therapeutics, Inc.
|
50
/ 100
| -1.2
| 31.0%
| -973.9%
| -80.7%
| -€1.99M
|
| Dr. Lal PathLabs Limited
|
50
/ 100
| 48
| 58.9%
| 29.1%
| 0.0%
| €11.93K
|
| Integrative Health Technologies, Inc.
|
50
/ 100
| -0.025
| 48.5%
| 56.2%
| -14.5%
| €0.00
|
| Psychemedics Corporation
|
50
/ 100
| -8.5
| 36.1%
| -9.6%
| -22.4%
| -€13.76K
|
| Avricore Health Inc.
|
50
/ 100
| -3.5
| 43.0%
| -20.7%
| -85.6%
| €0.00
|
| Vimta Labs Limited
|
50
/ 100
| 30
| 59.1%
| 25.2%
| 0.0%
| €5.05K
|
| Biocartis Group NV
|
50
/ 100
| -0.21
| 37.6%
| -89.6%
| -117.2%
| -€251.66K
|
| InVitro International
|
50
/ 100
| 13
| 81.7%
| 9.5%
| 6.0%
| €17.26K
|
| BIONET Corp.
|
50
/ 100
| 62
| 56.0%
| 1.4%
| 2.3%
| €0.00
|
| Applied DNA Sciences, Inc.
|
50
/ 100
| -0.065
| 39.6%
| -406.1%
| -373.5%
| -€692.09K
|
| TFBS Bioscience Inc.
|
50
/ 100
| -10
| 16.5%
| -29.4%
| -5.4%
| €0.00
|
| Australian Clinical Labs Limited
|
50
/ 100
| 9.7
| 32.6%
| 29.7%
| 9.8%
| €6.55K
|
| Danaher Corporation
|
77
/ 100
| 42
| 59.5%
| 19.0%
| 4.4%
| €49.27K
|
| Hangzhou Tigermed Consulting Co., Ltd.
|
50
/ 100
| 959
| 29.1%
| 6.5%
| 1.0%
| €3.52K
|
| Immunovia AB (publ)
|
50
/ 100
| -0.98
| -3,218.6%
| -10,914.6%
| -421.4%
| -€1.49M
|
| DermTech, Inc.
|
50
/ 100
| -0.00000039
| 8.5%
| -580.3%
| -87.0%
| -€373.31K
|
| Guangzhou Wondfo Biotech Co.,Ltd
|
50
/ 100
| 26
| 63.4%
| 16.0%
| 5.7%
| €15.00K
|
| Autobio Diagnostics Co., Ltd.
|
50
/ 100
| 19
| 65.0%
| 27.6%
| 9.8%
| €24.10K
|
| Monash IVF Group Limited
|
50
/ 100
| 14
| 32.3%
| 7.2%
| 3.8%
| €10.56K
|
| BioNexus Gene Lab Corp.
|
50
/ 100
| -1.9
| 14.1%
| -31.2%
| -31.1%
| -€83.89K
|
| Thalys Medical Technology Group Inc.
|
50
/ 100
| -9.6
| 19.4%
| -10.2%
| -11.9%
| -€22.50K
|
| Centro de Imagem Diagnósticos S.A.
|
50
/ 100
| -8.7
| 27.7%
| 9.6%
| -3.0%
| -€2.74K
|
| IQVIA Holdings Inc.
|
50
/ 100
| 21
| 33.8%
| 13.4%
| 4.5%
| €12.37K
|
| Diaceutics PLC
|
50
/ 100
| -0.24
| 81.4%
| -11.0%
| -9.8%
| -€27.12K
|
| Neuronetics, Inc.
|
50
/ 100
| -5.7
| 50.4%
| -29.2%
| -30.2%
| -€52.72K
|
| Precision System Science Co., Ltd.
|
50
/ 100
| -23
| 29.4%
| -2.6%
| -5.1%
| -€8.83K
|
| Integral Diagnostics Limited
|
50
/ 100
| -15
| 24.4%
| 12.3%
| -3.9%
| -€16.15K
|
| GRAIL, Inc.
|
50
/ 100
| -6.4
| -5.4%
| -471.3%
| -16.4%
| -€380.05K
|
| BioMaxima S.A.
|
50
/ 100
| 87
| 35.3%
| 2.2%
| 0.9%
| €1.44K
|
| Eurofins-Cerep SA
|
50
/ 100
| 7.7
| 25.4%
| 11.6%
| 15.9%
| €64.19K
|
| Access Bio, Inc.
|
50
/ 100
| -10
| 20.8%
| -42.1%
| -3.3%
| €0.00
|
| Castle Biosciences, Inc.
|
50
/ 100
| -44
| 65.3%
| -10.2%
| -2.2%
| -€13.39K
|
| Pacific Edge Limited
|
50
/ 100
| -1.3
| 48.0%
| -169.4%
| -160.6%
| -€259.15K
|
| Metropolis Healthcare Limited
|
50
/ 100
| 60
| 78.9%
| 25.3%
| 0.0%
| €3.36K
|
| RadNet, Inc.
|
53
/ 100
| 1.6K
| 30.3%
| 3.4%
| 0.1%
| €218.32
|
| VolitionRx Limited
|
50
/ 100
| -2.5
| 100.0%
| -1,779.0%
| -267.9%
| -€235.42K
|
| IDenta Corp.
|
50
/ 100
| -31
| 37.3%
| 2.2%
| -2.6%
| -€3.42K
|
| Arrayit Corporation
|
50
/ 100
| -0.01
| 49.4%
| -238.7%
| -749.5%
| -€927.41K
|
| Suraksha Diagnostic Limited
|
50
/ 100
| 48
| 80.8%
| 18.4%
| 0.0%
| €2.70K
|
| INOVIQ Ltd
|
50
/ 100
| -3.4
| -108.4%
| -886.6%
| -73.1%
| -€512.37K
|
| Eurofins Scientific SE
|
50
/ 100
| 19
| 11.7%
| 11.5%
| 5.3%
| €9.01K
|
| Acer Medical Inc.
|
50
/ 100
| -32
| 58.1%
| -65.6%
| -28.7%
| -€75.04K
|
| Lonza Group AG
|
50
/ 100
| 31
| 31.1%
| 16.8%
| 6.9%
| €77.31K
|
| BCAL Diagnostics Limited
|
50
/ 100
| -1.9
| 94.4%
| -285.4%
| -137.7%
| €0.00
|
| CareDx, Inc
|
50
/ 100
| 21
| 66.7%
| 11.8%
| 11.6%
| €68.85K
|
| bioAffinity Technologies, Inc.
|
50
/ 100
| -0.72
| 29.9%
| -131.0%
| -246.0%
| -€175.95K
|
| Diagnósticos da América S.A.
|
50
/ 100
| -1.9
| 28.6%
| 6.1%
| -4.9%
| -€8.97K
|
| Human Metabolome Technologies, Inc.
|
50
/ 100
| 13
| 65.9%
| 21.5%
| 11.9%
| €30.32K
|
| Sofiva Genomics Co.,Ltd.
|
50
/ 100
| -97
| 26.2%
| -8.6%
| -1.0%
| €0.00
|
| H.U. Group Holdings, Inc.
|
50
/ 100
| 131
| 28.0%
| 1.2%
| 0.5%
| €1.42K
|
| Welgene Biotech Co.,Ltd.
|
50
/ 100
| 205
| 42.4%
| 0.2%
| 0.4%
| €790.23
|
| Dian Diagnostics Group Co.,Ltd.
|
50
/ 100
| -21
| 28.7%
| -1.2%
| -2.9%
| -€5.97K
|
| Clínica Baviera, S.A.
|
50
/ 100
| 18
| 80.4%
| 28.4%
| 17.6%
| €22.92K
|
| Invitae Corporation
|
50
/ 100
| -0.0038
| 27.1%
| -303.5%
| -269.2%
| -€727.09K
|
| Genetics Generation Advancement Corp.
|
50
/ 100
| 45
| 41.7%
| 4.2%
| 4.9%
| €0.00
|
| Twist Bioscience Corporation
|
53
/ 100
| -25
| 49.2%
| -39.3%
| -13.2%
| -€79.19K
|
| Guardant Health, Inc.
|
56
/ 100
| -15
| 63.8%
| -49.0%
| -31.2%
| -€171.17K
|
| Shanghai Runda Medical Technology Co., Ltd.
|
50
/ 100
| -69
| 22.3%
| 1.5%
| -1.1%
| -€5.74K
|
| Amoy Diagnostics Co., Ltd.
|
50
/ 100
| 29
| 84.2%
| 31.0%
| 13.7%
| €31.84K
|
| Neogen Corporation
|
50
/ 100
| -1.2
| 43.8%
| -121.7%
| -30.9%
| -€306.81K
|
| Voxel S.A.
|
50
/ 100
| 17
| 28.6%
| 22.9%
| 16.2%
| €73.78K
|
| MDxHealth SA
|
50
/ 100
| -3.1
| 63.1%
| -26.7%
| -24.9%
| -€133.24K
|
| Bangkok Genomics Innovation Public Company Limited
|
50
/ 100
| 1.2K
| 41.3%
| 12.9%
| 6.6%
| €0.00
|
| DiaSorin S.p.A.
|
50
/ 100
| 27
| 65.7%
| 23.1%
| 6.6%
| €58.60K
|
| BioMark Diagnostics Inc.
|
50
/ 100
| -16
| 62.2%
| -751.3%
| -64.7%
| €0.00
|
| AmCad BioMed Corporation
|
50
/ 100
| -18
| 54.5%
| -170.4%
| -8.8%
| €0.00
|
| Thermo Fisher Scientific Inc.
|
62
/ 100
| 24
| 42.0%
| 17.2%
| 6.4%
| €45.10K
|
| SeqLL Inc.
|
50
/ 100
| -1.4
| 10.8%
| -6.9%
| -91.0%
| -€277.89K
|
| Pangaea Oncology, S.A.
|
50
/ 100
| -19
| 96.1%
| 4.0%
| -9.4%
| -€19.09K
|
| GENinCode plc
|
50
/ 100
| -0.0058
| 43.2%
| -253.9%
| -430.0%
| -€311.71K
|
| Cosmo Bio Company,Limited
|
50
/ 100
| 28
| 33.4%
| 2.8%
| 2.1%
| €7.77K
|
| Prostatype Genomics AB (publ)
|
50
/ 100
| -0.91
| -1,570.3%
| -5,798.6%
| -103.3%
| -€689.62K
|
| Maccura Biotechnology Co.Ltd
|
50
/ 100
| -62
| 53.9%
| -3.9%
| -1.5%
| -€4.24K
|
| Personalis, Inc.
|
50
/ 100
| -5.7
| 31.4%
| -89.6%
| -35.3%
| -€343.65K
|
| American Bio Medica Corporation
|
50
/ 100
| 0.0013
| -19.9%
| -439.3%
| 0.0%
| €194.98K
|
| Krsnaa Diagnostics Limited
|
50
/ 100
| 27
| 62.5%
| 23.5%
| 0.0%
| €2.07K
|
| RushNet, Inc.
|
50
/ 100
| -0.0062
| 64.0%
| -29.4%
| -30.6%
| -€66.19K
|
| StageZero Life Sciences Ltd.
|
50
/ 100
| -1.2
| 18.9%
| -97.5%
| -388.6%
| -€48.41K
|
| Charles River Laboratories International, Inc.
|
55
/ 100
| -107
| 32.3%
| 3.1%
| -0.9%
| -€3.18K
|
| Guangdong Hybribio Biotech Co.,Ltd.
|
50
/ 100
| -7
| 42.3%
| -74.9%
| -12.2%
| -€23.68K
|
| Agilent Technologies, Inc.
|
62
/ 100
| 28
| 53.0%
| 21.3%
| 10.0%
| €58.48K
|
| BML, Inc.
|
50
/ 100
| 19
| 31.9%
| 6.6%
| 3.7%
| €7.84K
|
| HTG Molecular Diagnostics, Inc.
|
50
/ 100
| -0.000011
| 21.7%
| -315.2%
| -185.5%
| -€326.23K
|
| Chembio Diagnostics, Inc.
|
50
/ 100
| -0.72
| 20.2%
| -48.9%
| -37.2%
| -€106.29K
|
| Genedrive Plc
|
50
/ 100
| -0.0076
| 51.3%
| -1,178.1%
| -308.6%
| -€328.73K
|
| Biosynex SA
|
50
/ 100
| -0.29
| -2.4%
| -39.3%
| -41.2%
| -€155.82K
|
| Genetic Signatures Limited
|
50
/ 100
| -2.3
| -73.7%
| -148.9%
| -69.5%
| €0.00
|
